°¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­ : ÄÄÆ÷³ÍÆ®, Àü°³ À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Infection Surveillance Solutions Market Report by Component (Software, Services), Deployment Type (On-premises, Cloud-based), End User (Hospitals, Clinics, Ambulatory Service Centers, Specialty Centers, and Others), and Region 2025-2033
»óǰÄÚµå : 1702114
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 141 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,171,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,561,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,952,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¨¿° °¨½Ã ¼Ö·ç¼Ç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 7¾ï 250¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 13¾ï 6,390¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 7.27%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI) Áõ°¡, °¨¿° È®»ê ¹æÁö¸¦ À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö, ȯÀÚ µ¥ÀÌÅÍ ÀÚµ¿ ¼öÁýÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ÇコÄɾî ITÀÇ ¹ßÀü µîÀÌ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°¨¿° °¨½Ã ¼Ö·ç¼ÇÀº ÀÇ·á±â°üÀÌ È¯ÀÚ Áý´Ü ³» °¨¿°ÀÇ À¯Çà, È®»ê ¹× ¿µÇâÀ» ¸ð´ÏÅ͸µÇÏ°í ºÐ¼®Çϱâ À§ÇØ Ã¤ÅÃÇÏ´Â Á¾ÇÕÀûÀÎ ½Ã½ºÅÛÀÔ´Ï´Ù. °í±Þ µ¥ÀÌÅÍ ¼öÁý, ÅëÇÕ ¹× ºÐ¼® µµ±¸¸¦ Ȱ¿ëÇÏ¿© Ç÷·ù °¨¿°, ¼ö¼ú ºÎÀ§ °¨¿°, È£Èí±â °¨¿° µî ´Ù¾çÇÑ ÀÇ·á °ü·Ã °¨¿°(HAI)À» ÃßÀûÇÏ°í º¸°íÇÕ´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ÀáÀçÀûÀÎ °¨¿° ¹ß»ýÀ» ½Å¼ÓÇÏ°Ô ½Äº°Çϰí, Ç¥ÀûÈ­µÈ °³ÀÔÀ» ½ÃÇàÇϸç, ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ Àü ¼¼°èÀûÀ¸·Î °¨¿° °¨½Ã ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÇöÀç °¨¿° °ü¸®¸¦ Æ÷ÇÔÇÑ È¯ÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ÇコÄɾ¼­ µ¥ÀÌÅÍ ±â¹Ý ÀÇ»ç°áÁ¤ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¨¿°¿¡ Ãë¾àÇÑ ³ëÀÎµé »çÀÌ¿¡¼­ °¨¿° °¨½Ã ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü¿°º´ ¹ß»ýÀ» ¸ð´ÏÅ͸µÇÏ°í ¿ÏÈ­Çϱâ À§ÇÑ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ºÐ¼®, ÀΰøÁö´É(AI), ¸Ó½Å·¯´×(ML) µîÀÇ ±â¼ú Çõ½ÅÀÌ °¨¿° °¨½Ã ¼Ö·ç¼ÇÀÇ ±â´ÉÀ» °­È­Çϰí È¿À²¼ºÀ» ³ô¿© ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Àü ¼¼°è ÀÇ·á ÀÎÇÁ¶ó ½Ã¼³ÀÇ °³¼±ÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

°¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå µ¿Çâ/ÃËÁø¿äÀÎ:

ÀÇ·á °ü·Ã °¨¿°(HAI) Áõ°¡

ÀÇ·á °ü·Ã °¨¿°(HAI) Áõ°¡·Î ÀÎÇØ °¨¿° °¨½Ã ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÌ·¯ÇÑ °¨¿°Àº ȯÀÚÀÇ °Ç°­À» À§ÇùÇϰí ÀÔ¿ø ±â°£ ¿¬Àå, ÀÇ·áºñ Áõ°¡, °æ¿ì¿¡ µû¶ó¼­´Â »ç¸ÁÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. À̿ʹ º°°³·Î, ȯÀÚÀÇ ¾ÈÀüÀ» À§ÇØ ÀÌ·¯ÇÑ °¨¿°À» ÁÙ¿©¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ȯÀÚ µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í ºÐ¼®ÇÔÀ¸·Î½á °¨¿°À» Á¶±â¿¡ ¹ß°ßÇϰí ÀÇ·á ±â°üÀÌ Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. °á°úÀûÀ¸·Î HAI°¡ °¨¼ÒÇϸé ȯÀÚÀÇ ¿¹Èİ¡ °³¼±µÉ »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á±â°üÀÇ ºñ¿ë Àý°¨À¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

°¨¿° È®»ê ¹æÁö¸¦ À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö

ÇコÄÉ¾î ¾÷°è¿¡¼­´Â ±ÔÁ¦ ¿ä°Ç°ú ÀÎÁõ ±âÁØÀ» ÁؼöÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ¸ÞµðÄɾî-¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)¿Í ÇÕµ¿À§¿øÈ¸(Joint Commission)¿Í °°Àº ±ÔÁ¦ ±â°üÀº ÀÇ·á °ü·Ã °¨¿°(HAI)ÀÇ º¸°í¿Í ¿¹¹æÀ» Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À̸¦ ÁؼöÇÏÁö ¾ÊÀ» °æ¿ì, ó¹úÀ̳ª ºÒÀÌÀÍÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿¡ ´õÇØ, °¨¿° °¨½Ã ¼Ö·ç¼ÇÀº ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °¨¿°·ü¿¡ ´ëÇÑ Á¤È®ÇÑ µ¥ÀÌÅÍ ¼öÁý, ºÐ¼® ¹× º¸°í¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© ÀÇ·á ½Ã¼³ÀÌ ±ÔÁ¦ ¿ä°ÇÀ» È¿À²ÀûÀ¸·Î ÃæÁ·ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, ÀÎÁõ ±â°üÀº °¨¿° °ü¸®¸¦ ÀÇ·á ¼­ºñ½ºÀÇ Áú¿¡ ÀÖ¾î Áß¿äÇÑ ¿ä¼Ò·Î °£ÁÖÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ±â°üÀº ±ÔÁ¦ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀÎÁõÀ» ȹµæÇϰí À¯ÁöÇÏ¸ç ÆòÆÇ°ú ½Å·Úµµ¸¦ ³ôÀÌ´Â µ¥ µµ¿òÀÌ µÇ´Â ÷´Ü °¨¿° °¨½Ã ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

ÇコÄɾî ITÀÇ ¹ßÀü

ÀüÀڰǰ­±â·Ï(EHR), ÀÇ·áÁ¤º¸±³·ù(HIE), ÅëÇÕÀÇ·á½Ã½ºÅÛÀÇ µµÀÔÀÌ ÁøÇàµÇ¸é¼­ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó °¨¿° °¨½Ã ¼Ö·ç¼ÇÀº ±âÁ¸ ÇコÄɾî IT ÀÎÇÁ¶ó¿Í ¿øÈ°ÇÏ°Ô ¿¬µ¿ÇÏ¿© ȯÀÚ µ¥ÀÌÅÍ, °Ë»ç °á°ú ¹× ±âŸ °ü·Ã Á¤º¸¸¦ ÀÚµ¿À¸·Î ¼öÁýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ ÀÎÅÍÆäÀ̽º´Â ¸ð´ÏÅ͸µ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í ºÐ¼®À» À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ °¡¿ë¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ÀÇ·á Àü¹®°¡µéÀº ÀáÀçÀûÀÎ ¹ßº´À» Á¶±â¿¡ ¹ß°ßÇÏ°í ´ëÀÀÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ½Ç¿ëÀûÀÎ ÅëÂû·Â¿¡ ºü¸£°Ô Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ¼Ö·ç¼Ç°ú ÀÇ·á IT´Â °¨¿° °ü¸®¸¦ °­È­ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀÇ·á ¼­ºñ½ºÀÇ Àü¹ÝÀûÀÎ È¿À²¼º°ú È¿°ú¼º¿¡µµ ±â¿©ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : ÄÄÆ÷³ÍÆ®º°

Á¦7Àå ½ÃÀå ºÐ¼® : Àü°³ À¯Çüº°

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global infection surveillance solutions market size reached USD 702.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,363.9 Million by 2033, exhibiting a growth rate (CAGR) of 7.27% during 2025-2033. The growing healthcare-associated infections (HAIs), stringent regulatory compliance for preventing the spread of infection, and advancements in healthcare IT that allow for the automatic capture of patient data are some of the major factors propelling the market.

Infection surveillance solutions are comprehensive systems that are employed by healthcare facilities to monitor and analyze the prevalence, spread, and impact of infections within their patient populations. They utilize advanced data collection, integration, and analysis tools to track and report on various healthcare-associated infections (HAIs), such as bloodstream infections, surgical site infections, and respiratory infections. As they enable healthcare providers to promptly identify potential outbreaks, implement targeted interventions, and ultimately enhance patient safety, the demand for infection surveillance solutions is increasing worldwide.

At present, the rising focus on patient safety, which includes infection control, is contributing to the growth of the market. In line with this, the increasing awareness about the importance of data-driven decision-making in healthcare is strengthening the growth of the market. Moreover, the growing demand for infection surveillance solutions among the geriatric population, as they are more vulnerable to infections, is positively influencing the market. In addition, rising investments in surveillance solutions to monitor and mitigate infectious disease outbreaks is offering lucrative growth opportunities to industry investors. Furthermore, innovations in data analytics, artificial intelligence (AI), and machine learning (ML) are enhancing the capabilities of infection surveillance solutions and making them more efficient is supporting the growth of the market. Besides this, the improving healthcare infrastructure facilities across the globe is bolstering the growth of the market.

Infection Surveillance Solutions Market Trends/Drivers:

Rising healthcare-associated infections (HAIs)

The rising adoption of infection surveillance solutions due to the increasing healthcare-associated Infections (HAIs) among individuals is contributing to the growth of the market. In line with this, these infections cause threats to patient well-being that lead to extended hospital stays, increased healthcare costs, and, in some cases, mortality. Apart from this, there is a rise in the need to mitigate these infections to enhance patient safety. By continuously monitoring and analyzing patient data, these solutions enable early detection of infections and allow healthcare facilities to implement timely interventions. Consequently, the reduction in HAIs not only improves patient outcomes but also leads to cost savings for healthcare organizations.

Stringent regulatory compliance for preventing spread of infection

In the healthcare industry, compliance with regulatory requirements and accreditation standards is vital. Regulatory bodies, such as the Centers for Medicare and Medicaid Services (CMS) and the Joint Commission are mandating the reporting and prevention of healthcare-associated infections (HAIs). In addition, failure to comply can result in penalties and reputational damage. Besides this, infection surveillance solutions are instrumental in ensuring compliance. They facilitate accurate data collection, analysis, and reporting of infection rates, helping healthcare facilities meet regulatory demands efficiently. Additionally, accreditation bodies focus on infection control as a critical component of healthcare quality. Furthermore, healthcare organizations are investing in advanced infection surveillance systems that not only satisfy regulatory needs but also contribute to achieving and maintaining accreditation, enhancing their reputation and trustworthiness.

Advancements in healthcare IT

The increasing adoption of electronic health records (EHRs), health information exchange (HIE), and integrated health systems is bolstering the growth of the market. In line with this, infection surveillance solutions can seamlessly interface with existing healthcare IT infrastructure and allow for the automatic capture of patient data, laboratory results, and other pertinent information. The interface of these systems streamlines the surveillance process and ensures the availability of real-time data for analysis, which is offering a positive market outlook. Healthcare professionals can access actionable insights quickly that aid in early detection and response to potential outbreaks. Moreover, these solutions and healthcare IT not only enhance infection control but also contribute to the overall efficiency and effectiveness of healthcare delivery.

Infection Surveillance Solutions Industry Segmentation:

Breakup by Component:

Software represents the largest market segment

Breakup by Deployment Type:

On-premises accounts for the majority of the market share

Breakup by End User:

Hospitals hold the biggest market share

Breakup by Region:

North America exhibits a clear dominance, accounting for the largest infection surveillance solutions market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. Apart from this, the rising focus on healthcare quality and patient safety is contributing to the growth of the market in the region. In line with this, stringent regulatory requirements in North America are necessitating the implementation of comprehensive infection surveillance solutions, which is propelling the growth of the market. Besides this, the rising demand for solutions that have real-time data and analytics capabilities is bolstering the growth of the market in the North America region.

Competitive Landscape:

Key manufacturers are continuously investing in research and development (R&D) activities to enhance the capabilities of their software and hardware. This includes developing advanced analytics, machine learning (ML) algorithms, and predictive modeling to improve infection detection and prevention. In addition, companies are working closely with healthcare facilities to customize their solutions and seamlessly integrate them into existing healthcare IT ecosystems. This ensures that the solutions align with the specific needs and workflows of each organization. Apart from this, solution providers are enhancing their data encryption, access controls, and compliance features to meet stringent healthcare regulations due to the increasing focus on data security and privacy. Furthermore, major players are offering cloud-based solutions to provide scalability, flexibility, and easier access to real-time data.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Infection Surveillance Solutions Market

6 Market Breakup by Component

7 Market Breakup by Deployment Type

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â